Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lab 2.0 Strategic Services is a private healthcare consulting and strategic advisory company focused on clinical laboratory transformation, diagnostics strategy, and value-based care. The firm appears to be led by founder and CEO Khosrow R. Shotorbani and is associated with the Clinical Lab 2.0 movement, which promotes using longitudinal laboratory data to generate actionable clinical and economic insights. Rather than developing therapeutic products, the company provides advisory, coaching, and strategy support to clinical laboratories and health-system stakeholders seeking to move from volume-based testing models toward decision-support and population-health-oriented lab services. Its work sits at the intersection of laboratory medicine, diagnostic stewardship, healthcare operations, and population health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lab 2.0 Strategic Services.